PTPκ Inhibitors are a class of chemical compounds that target and inhibit the activity of protein tyrosine phosphatase kappa (PTPκ), an enzyme belonging to the protein tyrosine phosphatase (PTP) family. PTPκ is a transmembrane receptor-type phosphatase that plays a critical role in cellular signaling pathways by dephosphorylating specific tyrosine residues on target proteins. This dephosphorylation process is essential for regulating various cellular functions, including cell adhesion, migration, and signaling cascades involved in cell growth and differentiation. PTPκ is particularly noted for its involvement in the regulation of cadherin-mediated cell-cell adhesion, a fundamental process in maintaining tissue architecture and integrity.
The use of PTPκ Inhibitors in research allows scientists to investigate the complex signaling networks that PTPκ influences, particularly those related to cell-cell communication and the maintenance of epithelial cell integrity. By inhibiting PTPκ activity, researchers can explore the downstream effects on cadherin-mediated adhesion and how disruptions in this process can affect cellular behavior. These inhibitors are valuable tools for studying the dynamics of cell adhesion molecules and their role in tissue morphogenesis, wound healing, and cellular response to environmental changes. Additionally, PTPκ Inhibitors provide insights into the broader regulatory mechanisms of tyrosine phosphorylation and dephosphorylation in cellular signaling networks, offering a deeper understanding of how cells coordinate their functions and maintain homeostasis. Overall, PTPκ Inhibitors are critical for advancing knowledge in cell biology, particularly in areas related to cell adhesion, signaling, and the intricate balance of phosphorylation states that govern cellular processes.
VOIR ÉGALEMENT...
Items 1 to 10 of 16 total
Afficher:
Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibe l'activité du PTPR en se liant à son site actif, empêchant ainsi son activité enzymatique. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Bloque la phosphorylation et l'activation de la PTPR, réduisant ainsi sa fonction de signalisation. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Inhibe l'activité du PTPR en se liant à son domaine kinase, empêchant l'autophosphorylation. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
Cible le PTPR et d'autres kinases, supprimant leur activation et la signalisation en aval. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Intervient dans la signalisation du PTPR en inhibant sa phosphorylation et son activation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Perturbe les cascades de signalisation médiées par la PTPR en inhibant son domaine kinase. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Supprime l'activité du PTPR en bloquant son domaine kinase, ce qui entrave les effets en aval. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
Cible le PTPR et d'autres kinases, altérant leurs fonctions de signalisation. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | $255.00 | ||
Inhibe la signalisation de la PTPR en se liant à son domaine kinase et en empêchant son activation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
Inhibiteur non spécifique connu des protéines tyrosine phosphatases, qui peut inhiber l'activité de la PTPR en imitant l'état de transition du substrat de l'enzyme. |